Clinical Trials Logo

Filter by:
NCT ID: NCT03109600 Completed - Safety Issues Clinical Trials

Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)

Start date: April 18, 2017
Phase: Phase 1
Study type: Interventional

This study is to assess the safety of Vi-DT vaccine in adults and children.

NCT ID: NCT03106285 Withdrawn - Colic, Infantile Clinical Trials

Effectiveness of Probiotic Supplementation on Crying Time in Infantile Colic

Start date: April 14, 2017
Phase: N/A
Study type: Interventional

This study aims to investigate the effectiveness of Lactobacillus reuteri DSM17938 supplementation on infantile colic in Indonesian infants.

NCT ID: NCT03099213 Completed - Clinical trials for Coronary Artery Disease

An Open-label, Non-comparative Study to Document the Tolerability to Ramipril in Patients With at Least One High Risk for Developing a Major Cardiovascular Event

HOPETips
Start date: November 1, 2008
Phase: Phase 4
Study type: Interventional

Primary Objective: To document the tolerability of patients receiving study medication at 12-week of therapy in terms of the scoring system assessed by the investigator. Secondary Objectives: - To document drug safety at 12-week of treatment in terms of number of Adverse Drug Reaction or Serious Adverse Drug Reaction reported. - To describe the population treated as per the HOPE study indication in current clinical practice (demographics, cardiovascular risk-factors at treatment initiation, concomitant treatments patterns).

NCT ID: NCT03095326 Completed - Thalassemia Clinical Trials

Pneumococcal Vaccination for Splenectomised Thalassemia Major Patients in Indonesia

Start date: September 1, 2013
Phase: Phase 4
Study type: Interventional

Splenectomized thalassemia major subjects were provided with PCV pneumococcal vaccine (Prevenar 13®) at the start of the trial, following which they were randomly assigned to 2 groups (zinc and placebo group). After 8 weeks, the subjects received PPV pneumococcal vaccine (Pneumovax®). Zinc syrup was provided to the zinc group at a dose of 1.5 mg/kg/day (maximum of 50 mg/day). Pneumococcal IgG examinations were conducted at the start of the trial and after 12 weeks.

NCT ID: NCT03092817 Completed - HIV Clinical Trials

Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial)

Start date: May 25, 2017
Phase: Phase 3
Study type: Interventional

The investigators will conduct a randomized, double blind, placebo controlled trial of adjunctive dexamethasone in the initial (6-8 weeks) treatment of tuberculous meningitis in Vietnamese adults. The trial will address a primary hypothesis in all enrolled patients, and a secondary hypothesis in a sub-group of enrolled patients who develop anti-tuberculosis drug-induced liver injury (DILI). The primary hypothesis is adjunctive dexamethasone increases survival from TBM in HIV co-infected adults. The secondary hypothesis is current guidelines for the management of anti-tuberculosis drug-induced liver injury in those with TBM result in the premature interruption of rifampicin and isoniazid (the critical active drugs in early therapy) and are thereby placing participants at risk of poor outcomes.

NCT ID: NCT03085940 Completed - Clinical trials for Rheumatoid Arthritis

Role of Hydroxychloroquine to Improve Endothelial Dysfunction in Patients With Rheumatoid Arthritis

Start date: January 20, 2017
Phase: N/A
Study type: Interventional

Rheumatoid arthritis (RA) increase cardiovascular risk and endothelial dysfunction. Hydroxychloroquine (HCQ) is expected to improve endothelial dysfunction through some metabolic effects. The investigators intend to find the role of HCQ to improve endothelial dysfunction in RA patients. This study will also evaluate correlation HOMA-IR (homeostasis model assessment-estimated insulin resistance), FFA (free fatty acid) and ox-LDL (oxidized-LDL) level change, with endothelial dysfunction improvement.

NCT ID: NCT03058263 Completed - General Anesthesia Clinical Trials

Effect of Neostigmine on the Recovery of Rocuronium: A Comparison Between Partial and TOF Ratio-Based Dose

Start date: October 2016
Phase: Phase 1/Phase 2
Study type: Interventional

This study aimed to evaluate the effect of Neostigmine partial dose towards neuromuscular blockade of rocuronium

NCT ID: NCT03055585 Terminated - Dengue Clinical Trials

Applying Wolbachia to Eliminate Dengue

AWED
Start date: November 8, 2017
Phase: N/A
Study type: Interventional

This cluster randomised trial will evaluate the efficacy of Wolbachia-infected Aedes aegytpi mosquitoes in reducing dengue cases in Yogyakarta City, Indonesia

NCT ID: NCT03054233 Completed - Caesarian Section Clinical Trials

Comparison of Successful Spinal Needle Insertion Between Obese and Non-obese Pregnant Women

Start date: July 2016
Phase: N/A
Study type: Interventional

The study aimed to compare successful spinal needle insertion between obese and non-obese pregnant women in crossed leg sitting position undergoing cesarean section

NCT ID: NCT03051022 Completed - Clinical trials for Lower Extremities Fracture

Comparison Between Dexamethasone and Morphine as an Adjuvant to Bupivacaine for Post-operative Analgesia

Start date: May 1, 2016
Phase: N/A
Study type: Interventional

The study aimed to compare the effectivity of dexamethasone 8 mg and morphine 2 mg as an adjuvant to epidural bupivacaine 0,125% 12,5mg for post-operative analgesia in lower extremities.